“Pediatric Neuromuscular Disorders in the Age of Disease Modifying Therapies”

Presented by:   

Hovig K. Artinian, MD, MAT, FAAP; Pediatric Pulmonology and Sleep Medicine, UCSF Fresno AND

Jena Krueger, MD; Pediatric Neurology- Helen DeVos Children's Hospital, Grand Rapids, MI                                                                                 

Planners expect learners to:

1. Recognize new disease modifying therapy in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy.

2. Assess the challenges in utilizing new disease modifying therapy, including safety, cost, access and the wide spectrum of disease.

3. Describe pulmonary manifestations of neuromuscular diseases.

4. Develop treatment plan to manage pulmonary manifestations of neuromuscular diseases, including adjusting patient’s treatments after disease modifying therapy.

UCSF Benioff Children’s Hospital Oakland is accredited by the California Medical Association to provide continuing medical education for physicians.

UCSF Benioff Children’s Hospital Oakland designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For CME credit, online evaluations must be completed by 12pm on the Friday after Grand Rounds.  Requests for the link to the current evaluation must be sent to Cristina.Fernandez@ucsf.edu by NOON on the day of Grand Rounds.